Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. Markets Digest The Fed's Hawkish Pause, Wait For ECB
  2. MicroStrategy To Purchase More Bitcoin From Proceeds Of A $500 Million Stock Sale
  3. Crypto Analyst Alex Krüger on Bitcoin Price: ‘30K-35K Looks Very Doable’
  4. Why Vitalik Buterin Is ‘Actually Kinda Happy a Lot of the ETFs Are Getting Delayed’
  5. Why Ether Will Drastically Outperform Bitcoin In 2024